Common GI Disorders Medications

Article

Rabeprazole (Aciphex)

Lubiprostone (Amitiza)

Mesalamine Delayed-Release Tablets (Asacol)

Mesalazine

More GI Disorders Medications

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
Related Content
The TikTok Doc Is In: But Will Your Patient Trust the Diagnosis?

The TikTok Doc Is In: But Will Your Patient Trust the Diagnosis?

Grace Halsey
August 9th 2025
Article
The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Sydney Jennings
August 9th 2025
Podcast
Novel Plasma Assays That Selectively Detect Tau Characteristics Will Refine Clinical Study of Alzheimer Disease / image credit Courtesy of C2N Diagnostics

Novel Plasma Assays That Selectively Detect Tau Characteristics Will Refine Clinical Study of Alzheimer Disease

Grace Halsey
August 9th 2025
Article
Make It Routine: Screening for Cognitive Decline in Primary Care

Make It Routine: Screening for Cognitive Decline in Primary Care

Anna Chodos, MD, MPH;Sydney Jennings
August 9th 2025
Podcast
Use of Weight-Loss Drugs Increased Among US Adolescents After AAP Guideline Release

Use of Weight-Loss Drugs Increased Among US Adolescents After AAP Guideline Release

Sydney Jennings
August 9th 2025
Article
Lilly's Oral GLP-1 Agonist Orforglipron Linked to Weight Reduction of 12.4% in Pivotal Phase 3 Trial / image credit ©MichaelVI/stock.adobe.com

Lilly's Oral GLP-1 Agonist Orforglipron Linked to Weight Reduction of 12.4% in Pivotal Phase 3 Trial

Grace Halsey
August 9th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.